Mumbai, India

Vikas Vasant Nawathye



Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Innovator Spotlight: Vikas Vasant Nawathye**

Introduction

Vikas Vasant Nawathye is a noteworthy inventor based in Mumbai, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antifungal agents. With a focus on innovative compounds, his work stands out in the realm of medicinal chemistry.

Latest Patents

Nawathye holds a patent for "Enantiomers of fluconazole analogues containing thieno-[2,-3-D]pyrimidin-4(3H)-one moiety as antifungal agents." This patent discloses novel enantiomeric antifungal compounds characterized by specific structural formulas. His invention covers the methods of preparing these compounds, their use in the prevention and treatment of fungal infections, and the pharmaceutical preparations that include these compounds.

Career Highlights

Throughout his career, Vikas Vasant Nawathye has gained valuable experience working with renowned organizations. He has been associated with FDC Limited, where he contributed to pharmaceutical advancements, and the Council of Scientific & Industrial Research, a key body in India's scientific research landscape. His endeavors have greatly influenced the development of new medications.

Collaborations

During his professional journey, Nawathye has collaborated with several accomplished individuals, including Hanumant Bapurao Borate and Suleman Riyajsaheb Maujan. These collaborations have likely enriched his work and expanded the impact of his inventions in the pharmaceutical industry.

Conclusion

Vikas Vasant Nawathye is an exemplary inventor whose patent for antifungal compounds illustrates the potential for innovation in medicine. His contributions through collaborations and his career path demonstrate his commitment to enhancing healthcare solutions. The significance of his work continues to resonate within the scientific community, paving the way for future advancements in the treatment of fungal infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…